2019•Multiple Sclerosis and Related DisordersRequires access

Comparative analysis of fingolimod versus teriflunomide in relapsing–remitting multiple sclerosis

Cavit Boz, Murat Terzi, Bilge Özer, Recai Türkoğlu, Rana Karabudak, Hüsnü Efendi, Aysun Soysal, Serhan Sevim, Ayşe Altıntaş, Aslı Kurne, Aylin Akçalı, Gülşen Akman, Nur Yüceyar, Belgin Petek Balcı, Özgül Ekmekçi, Serap Zengin Karahan, Meltem Demirkıran, Burcu Altunrende, Ömer Faruk Turan, Gokcen Gozubatik‐Celik, Nilüfer Kale, Mesrure Köseoğlu, Serkan Özakbaş

Open publisher page 6 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 6 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Fingolimod, Teriflunomide, Medicine, Multiple sclerosis, Expanded Disability Status Scale, Internal medicine, Observational study, Relapsing remitting